Centiva Capital’s Tourmaline Bio TRML Stock Holding History

Centiva Capital’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-50,000	Closed	-$2.39M	–	1596
2025 Q3	$2.39M	Buy	+50,000	New	+$1.39M	0.02%	348

Centiva Capital's TRML Position: Q4 2025 in Review

Centiva Capital sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 50,000 shares — an estimated $2.39M sold.

Centiva Capital first reported a position in TRML in Q3 2025 and held it in 1 quarter. The position peaked at $2.39M in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

Centiva Capital reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
Centiva Capital sold 50,000 Tourmaline Bio shares in Q4 2025, an estimated $2.39M.
Centiva Capital first reported a position in Tourmaline Bio in Q3 2025 and held it in 1 quarter.
Centiva Capital's Tourmaline Bio position peaked at $2.39M in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Centiva Capital's 13F filing for Q4 2025, filed 13 Feb 2026.